30 related articles for article (PubMed ID: 887501)
1. Monitoring the Level of
Kalász H; Tekes K; Faigl EB; Pöstényi Z; Berekméri E; Karvaly G; Adeghate E
Open Med Chem J; 2017; 11():1-8. PubMed ID: 28567124
[TBL] [Abstract][Full Text] [Related]
2. A comparison of drug-seeking behavior maintained by D-amphetamine, L-deprenyl (selegiline), and D-deprenyl under a second-order schedule in squirrel monkeys.
Yasar S; Gaál J; Panlilio LV; Justinova Z; Molnár SV; Redhi GH; Schindler CW
Psychopharmacology (Berl); 2006 Jan; 183(4):413-21. PubMed ID: 16292593
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on MAO-B in aging and neurological disease: where do we go from here?
Kumar MJ; Andersen JK
Mol Neurobiol; 2004 Aug; 30(1):77-89. PubMed ID: 15247489
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of anti-parkinsonian drugs.
Cedarbaum JM
Clin Pharmacokinet; 1987 Sep; 13(3):141-78. PubMed ID: 3311529
[TBL] [Abstract][Full Text] [Related]
5. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
Severina IS
Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
Deverina IS
Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
[TBL] [Abstract][Full Text] [Related]
7. [Effect of new 2-propinylamine derivatives on mitochondrial monoamine oxidase activity].
Shatemirova KK; Davydova GA; Verevkina IV; Tichilkin AI
Vopr Med Khim; 1977; 23(5):609-18. PubMed ID: 595495
[TBL] [Abstract][Full Text] [Related]
8. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
Severina IS; Klimova GI; Nersisian AA
Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
[TBL] [Abstract][Full Text] [Related]
9. [Baygon (2-isopropoxyphenyl-N-methyl carbamate) activation of enzymatic deamination of 2-phenyl-ethylamine].
Zeĭnalov TA
Vopr Med Khim; 1985; 31(5):60-4. PubMed ID: 4090367
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of the "B form" of monoamine oxidase.
Magyar K; Knoll J
Pol J Pharmacol Pharm; 1977; 29(3):233-46. PubMed ID: 887501
[TBL] [Abstract][Full Text] [Related]
11. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
Knoll J
Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
[TBL] [Abstract][Full Text] [Related]
12. Selective MAO A and B inhibitors: their mechanism of action and pharmacology.
Finberg JP; Youdim MB
Neuropharmacology; 1983 Mar; 22(3 Spec No):441-6. PubMed ID: 6304562
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
